Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD-Reference-Cited by-同舟云学术

Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD

Published:2020-03 Issue:3 Volume:5 Page:331-338
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Hanset Nicolas,Esteve Emmanuel,Plaisier Emmanuelle,Johanet Catherine,Michel Pierre-Antoine,Boffa Jean-Jacques,Fievet Patrick,Mesnard Laurent,Morelle Johann,Ronco Pierre,Dahan Karine

Publisher

Elsevier BV

Subject

Nephrology

Reference30 articles.

1. Glomerular diseases: membranous nephropathy—a modern view;Ponticelli;Clin J Am Soc Nephrol,2014

2. Prognosis of untreated patients with idiopathic membranous nephropathy;Schieppati;N Engl J Med,1993

3. KDIGO clinical practice guideline for glomerulonephritis;Kidney Int,2012

4. M-type phospholipase A2 receptor as target antigen in idiopathic MN;Beck;N Engl Med J,2009

5. Antiphospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy;Ruggenenti;J Am Soc Nephrol,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membranous nephropathy: pathogenesis and treatments;MedComm;2024-06-29

2. Prospective study of the effect of rituximab on kidney function in membranous nephropathy;Clinical Kidney Journal;2024-06-18

3. An Updated Review of Membranous Nephropathy;Indian Journal of Nephrology;2024-04-10

4. Longitudinal Assessment of Health-Related Quality of Life in Three Different Hyperphosphatemia Management Groups of Stage Ⅲ and Ⅳ Chronic Kidney Disease Patients;Indian Journal of Nephrology;2023-09-29

5. Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study;Renal Failure;2023-07-24